Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Mouth Neoplasms 1

Interventions

Cisplatin 4Radiotherapy, Intensity-Modulated 3Radiotherapy 3pembrolizumab 2Cetuximab 2Biopsy 2utomilumab 1tremelimumab 1motexafin gadolinium 1durvalumab 1antineoplaston AS 2-1 1antineoplaston A10 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiosurgery 1Radiation 1Platinum 1Observation 1Nivolumab 1Ipilimumab 1Immunohistochemistry 1Immunoglobulin G 1Fluorouracil 1Fluorescent Antibody Technique 1Flow Cytometry 1Etoposide 1Electroacupuncture 1Drug Therapy 1Disulfides 1Diagnosis, Oral 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Oropharyngeal Neoplasms × Diagnosis, Oral × Clear all
NCT03555721 2023-05-10

CytID Analysis of Oral Lesions

The University of Texas Health Science Center, Houston

Terminated
18 enrolled
Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡